It was approved in the UK in June 2026 as the first oral GLP1 medicine licensed specifically for weight management, offering a needle free alternative to the weekly Wegovy injection.Unlike a standard tablet, it must be taken first thing in the morning after fasting for at least 8 hours, swallowing the tablet whole with a small sip of plain water (up to 120 mL)
Contact your GP if you experience absent periods for three months or more, very heavy bleeding requiring hourly pad changes, bleeding between periods, severe pelvic pain, or any possibility of pregnancy
Diagnosis, STATs twice-weekly newsletter about the politics and policy of health and medicine
Based on this information, theyll decide if tirzepatide is right for you
It represents a next-generation incretin-based compound of significant interest in metabolic disease research, with studied effects on energy homeostasis, insulin secretion, and lipid metabolism in preclinical models